Shuncong Wang

1.1k citations
40 papers · 773 indexed · h-index 16
Topics
Hepatocellular Carcinoma Treatment and Prognosis (6 papers)Lung Cancer Treatments and Mutations (5 papers)Lung Cancer Research Studies (5 papers)

In The Last Decade

Shuncong Wang

38 papers receiving 770 citations

Peers

Shuncong Wang
Comparison fields: 5 of 98
  • Oncology 349
  • Pulmonary and Respiratory Medicine 211
  • Molecular Biology 209
  • Epidemiology 143
  • Cancer Research 98
Replace Nagla Abdel Karim with:
Nagla Abdel Karim United States
M. Puglisi Italy
Joo Han Lim South Korea
Cecilie L. Bager Denmark
Ernest Marshall United Kingdom
Hongyu Zhang China
Joline S.J. Lim Singapore
Gordon Moody United States
Preston D. Steen United States
Dengfeng Ren China
Shuncong Wang relative to Nagla Abdel Karim United States Nagla Abdel Karim's profile →
Citations per field
00.5×1.5×
Nagla Abdel Karim · 1×
Citations per year

Countries citing papers authored by Shuncong Wang

Since Specialization
Citations

This map shows the geographic impact of Shuncong Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuncong Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuncong Wang more than expected).

Fields of papers citing papers by Shuncong Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuncong Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuncong Wang. The network helps show where Shuncong Wang may publish in the future.

Co-authorship network of co-authors of Shuncong Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Shuncong Wang. A scholar is included among the top collaborators of Shuncong Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuncong Wang. Shuncong Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 2
4 8
5 4
6 1
7 4
8 3
9 5
10 6
11 3
12 15
13 3
14 20
15 8
16 8
17 12
18 25
19 141
20 42

About Shuncong Wang

Shuncong Wang is a scholar working on Hepatology, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 40 papers that have together received 773 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Lung Cancer Treatments and Mutations (5 papers) and Lung Cancer Research Studies (5 papers). The work is most often cited by research in Oncology (349 citations), Hepatology (71 citations) and Cancer Research (98 citations). Shuncong Wang has collaborated with scholars based in China, Belgium and United States. Frequent co-authors include Huanhuan Sun, Yicheng Ni, Yuanbo Feng, Haiqing Ma, Cuiling Zhou, Xiuling Zhou, Tiantian Sun, Zhibin Cheng, Hongliu Sun and Jie Li. Their work appears in journals such as Nature Communications, Scientific Reports and International Journal of Pharmaceutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026